On August 10, 2026, Novo Nordisk and Amazon Web Services (AWS) unveiled a strategic partnership. Under this agreement, AWS will serve as Novo Nordisk's go-to cloud service provider and strategic AI collaborator. The duo plans to establish an AI-driven collaborative innovation center in London. By harnessing the power of agentic artificial intelligence, cloud technology, and their unique strengths, they aim to expedite drug discovery, streamline operations, and trim down the timeline from identifying drug targets to administering the first-in-human doses.